Kuroda Seika, Solari Valeria, Puri Prem
Children's Research Centre, Our Lady's Children's Hospital, Dublin, Ireland.
J Urol. 2007 Oct;178(4 Pt 2):1650-3. doi: 10.1016/j.juro.2007.03.199. Epub 2007 Aug 16.
Familial clustering of vesicoureteral reflux suggests that genetic factors have an important role in the pathogenesis of vesicoureteral reflux. Transforming growth factor-beta1 is a multifunctional peptide that controls proliferation and differentiation in many cell types. Recently an association between the transforming growth factor-beta1 -509 and +869 gene polymorphism, and renal parenchymal scarring was reported. We investigated the genetic contribution of transforming growth factor-beta1 in familial vesicoureteral reflux by examining the genotype frequencies of transforming growth factor-beta1 polymorphic variants.
The study included 141 families in which 1 or more siblings had primary vesicoureteral reflux. Renal parenchymal scarring was assessed using dimercapto-succinic acid scans. Genotyping was performed in 280 patients with vesicoureteral reflux, including 133 index patients and 147 siblings, and in 74 controls for the position -509 and the coding region at position 10 (+869) of the transforming growth factor-beta1 gene polymorphism by polymerase chain reaction, gel analysis and appropriate restriction digest.
The genotype frequency of -509CC was significantly increased in the familial vesicoureteral reflux group compared to controls (58% vs 33%, p <0.01), whereas -509TT genotype frequency was significantly lower in the familial vesicoureteral reflux group compared to controls (7.5% vs 28%, p <0.01). Similarly there was a significant increase in the +869TT genotype (52% vs 32%, p <0.05), while the +869CC genotype was significantly lower in patients with familial vesicoureteral reflux compared to controls (11% vs 24%, p <0.01). There were no significant differences in transforming growth factor-beta1 genotype distribution between patients with vesicoureteral reflux with and without renal parenchymal scarring.
To our knowledge this study demonstrates for the first time the association of the cytokine transforming growth factor-beta1 gene polymorphism in patients with familial vesicoureteral reflux. Individuals with the transforming growth factor-beta1 -509CC and 869TT genotype may have increased susceptibility to vesicoureteral reflux.
膀胱输尿管反流的家族聚集现象表明遗传因素在膀胱输尿管反流的发病机制中起重要作用。转化生长因子β1是一种多功能肽,可控制多种细胞类型的增殖和分化。最近有报道称转化生长因子β1 -509和+869基因多态性与肾实质瘢痕形成有关。我们通过检测转化生长因子β1多态性变体的基因型频率,研究了转化生长因子β1在家族性膀胱输尿管反流中的遗传作用。
该研究纳入了141个家庭,其中1个或多个兄弟姐妹患有原发性膀胱输尿管反流。使用二巯基琥珀酸扫描评估肾实质瘢痕形成情况。对280例膀胱输尿管反流患者进行基因分型,包括133例索引患者和147例兄弟姐妹,以及74例对照,通过聚合酶链反应、凝胶分析和适当的限制性酶切对转化生长因子β1基因多态性的-509位点和第10位编码区(+869)进行基因分型。
与对照组相比,家族性膀胱输尿管反流组中-509CC基因型频率显著升高(58%对33%,p<0.01),而家族性膀胱输尿管反流组中-509TT基因型频率显著低于对照组(7.5%对28%,p<0.01)。同样,+869TT基因型显著增加(52%对32%,p<0.05),而家族性膀胱输尿管反流患者中+869CC基因型显著低于对照组(11%对24%,p<0.01)。有或无肾实质瘢痕形成的膀胱输尿管反流患者之间,转化生长因子β1基因型分布无显著差异。
据我们所知,本研究首次证明了细胞因子转化生长因子β1基因多态性与家族性膀胱输尿管反流患者的相关性。具有转化生长因子β1 -509CC和869TT基因型的个体可能对膀胱输尿管反流的易感性增加。